Health Care & Life Sciences » Pharmaceuticals | KYORIN Holdings Inc.

KYORIN Holdings Inc. | Ownership

Companies that own KYORIN Holdings Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,104,593
1.47%
-1,900
0%
07/31/2018
Norges Bank Investment Management
1,085,569
1.45%
-23,139
0%
12/31/2017
Nomura Asset Management Co., Ltd.
952,098
1.27%
-32,395
0.01%
07/31/2018
Dimensional Fund Advisors LP
808,500
1.08%
144,800
0%
04/30/2018
BlackRock Fund Advisors
503,300
0.67%
200
0%
09/06/2018
Daiwa Asset Management Co. Ltd.
455,900
0.61%
-27,000
0.01%
07/31/2018
Nikko Asset Management Co., Ltd.
413,099
0.55%
-13,701
0.01%
08/20/2018
Lingohr & Partner Asset Management GmbH
230,968
0.31%
50,468
0.34%
08/31/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
224,133
0.3%
35,633
0.01%
07/31/2018
BNY Mellon Asset Management North America Corp.
197,129
0.26%
-2,100
0%
09/06/2018

About KYORIN Holdings

View Profile
Address
Ochanomizu Sola City, 16/F
Tokyo Tokyo 101
Japan
Employees -
Website http://www.kyorin-gr.co.jp
Updated 07/08/2019
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the following segments: Pharmaceutical Business and Healthcare Business. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs.